Treating patients with high - dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from
a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.
Not exact matches
TRINOVA - 1 was a
randomized prospective phase III clinical trial that added trebananib or placebo to standard chemotherapy (weekly paclitaxel) among 919 women with recurrent ovarian cancer patient from 179 sites in 32 countries.
The
phase 2 program was comprised of two
prospective,
randomized double - blind, placebo - controlled, parallel group trials (ATHENA and ATHENA II).
Ludwig, M., Finas, A., Katalinic, A., Strik, D., Kowalcek, I., Schwartz, P., Felberbaum, R., Kupker, W., Schopper, B., Al - Hasani, S., and Diedrich, K.
Prospective,
randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal
phase support.
Geusa S, Causio F Marinaccio M Stanziano A Sarcina E. Luteal
phase support with progesterone in IVF / ET cycles: a
prospective,
randomized study comparing vaginal and intramuscular administration [abstract].
A
prospective randomized study comparing hCG, vaginalmicronized porgesterone and a combination regimen for luteal
phase support in an in - vitro fertilization programme [abstract].